ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,665, issued on Aug. 11, was assigned to The United States of America, As Represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"ExoVII inhibitor and quinolone antibiotic combination useful for treating bacterial infection" was invented by Yves Georges Pommier (Bethesda, Md.) and Shar-yin Naomi Huang (Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides a method of treating or preventing a bacterial infection in a subject comprising administering a therapeutically effective amount of a combination of a bacterial type IIA topoisomerase inhibitor, or a pharmaceutically acceptable salt the...